Oncolytic Vaccinia Virus Carrying <i>Aphrocallistes vastus</i> Lectin (oncoVV-AVL) Enhances Inflammatory Response in Hepatocellular Carcinoma Cells

<i>Aphrocallistes vastus</i> lectin (AVL) is a C-type marine lectin derived from sponges. Our previous study demonstrated that oncolytic vaccinia virus carrying AVL (oncoVV-AVL) significantly enhanced the cytotoxicity of oncoVV in cervical cancer, colorectal cancer and hepatocellular car...

Full description

Bibliographic Details
Main Authors: Xinnan Zheng, Weizhe Xu, Qi Ying, Jiajun Ni, Xiaoyuan Jia, Yanrong Zhou, Ting Ye, Gongchu Li, Kan Chen
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/20/11/667
Description
Summary:<i>Aphrocallistes vastus</i> lectin (AVL) is a C-type marine lectin derived from sponges. Our previous study demonstrated that oncolytic vaccinia virus carrying AVL (oncoVV-AVL) significantly enhanced the cytotoxicity of oncoVV in cervical cancer, colorectal cancer and hepatocellular carcinoma through the activation of Ras/ERK, MAPK/ERK and PI3K/Akt signaling pathways. In this study, the inflammatory response induced by oncoVV-AVL in a hepatocellular carcinoma cell (HCC) model was investigated. The results showed that oncoVV-AVL increased the levels of inflammatory cytokines including IL-6, IL-8 and TNF-α through activating the AP-1 signaling pathway in HCC. This study provides novel insights into the utilization of lectin AVL in the field of cancer therapy.
ISSN:1660-3397